Page 235 - Tata_Chemicals_yearly-reports-2021-22

01 INTEGRATED 73 STATUTORY 178 FINANCIAL
REPORT
STATEMENTS
REPORTS
Standalone

(vi) Assumptions used in accounting for gratuity, post retirement medical benefits, directors' retirement obligations and family
benefit scheme:
Gratuity and Directors'
Post retirement
Particulars Compensated medical benefits retirement Family benefit
scheme
absences obligations
Discount rate As at March 31, 2022 7.00% 7.00% 7.00% 7.00%
As at March 31, 2021 6.50% 6.50% 6.50% 6.50%
Increase in Compensation cost As at March 31, 2022 7.50% NA 7.50% 7.50%
As at March 31, 2021 7.50% NA 7.50% 7.50%
Healthcare cost increase rate As at March 31, 2022 NA 10.00% 8.00% NA
As at March 31, 2021 NA 10.00% 8.00% NA
Pension increase rate As at March 31, 2022 NA NA 6.00% NA
As at March 31, 2021 NA NA 6.00% NA
(a) Discount rate is based on the prevailing market yields of Indian Government securities as at the Balance Sheet date for the estimated
term of the obligations.
(b) The estimates of future salary increases considered in actuarial valuation take into account the inflation, seniority, promotion and
other relevant factors.

233